Next Article in Journal
The Mediating Role of Rumination in the Relationship between Loneliness and Depression in University Students during the COVID-19 Pandemic
Previous Article in Journal
Temporal Analysis of SARS-CoV-2 Variants during the COVID-19 Pandemic in Nepal
 
 
Article

A Throat Lozenge with Fixed Combination of Cetylpyridinium Chloride and Benzydamine Hydrochloride Has Direct Virucidal Effect on SARS-CoV-2

Faculty of Medicine, Institute of Microbiology and Immunology, University of Ljubljana, Zaloška 4, SI-1000 Ljubljana, Slovenia
*
Author to whom correspondence should be addressed.
Academic Editor: Cheng-Wen Lin
COVID 2021, 1(2), 435-446; https://doi.org/10.3390/covid1020037
Received: 12 July 2021 / Revised: 31 August 2021 / Accepted: 7 September 2021 / Published: 26 September 2021
(This article belongs to the Topic Broad-Spectrum Antiviral Agents)
Viruses are the most common causative agents of inflammation in the oral cavity and throat region. Most respiratory tract infections are self-limiting and require no specific treatment. However, patients often use different self-medication therapies that can treat both the symptoms and the cause. Throat lozenges with a fixed combination of benzydamine hydrochloride and cetypiridinium chloride (BH/CPC) have been shown to provide effective symptomatic relief for sore throat, but their effect on viruses has not been investigated to date. The antiseptic, cetylpyridinium chloride (CPC), has already been described as a successful bactericide. In addition, there are some studies suggesting its efficacy against certain enveloped viruses. Thus, the aim of our study was to examine the virucidal activity of CPC and a combination of BH/CPC as a free active substance or as lozenge on SARS-CoV-2 in vitro. Under in-laboratory simulated conditions of lozenge administration, we incubated SARS-CoV-2 with three different concentrations of each of the active substances, CPC, free BH/CPC or BH/CPC, as a lozenge suspension for 1 min, 5 min and 15 min of contact time. Infective viral particles were detected in cell cultures and the viral titre was calculated accordingly. Our results show that all active substances in high-concentration suspensions, as well as a medium concentration of the BH/CPC combination, exhibited a 4-log reduction in viral titre. Additionally, the highest concentration of BH/CPC as a lozenge had a faster virucidal effect compared to CPC as a free active substance alone, since a contact time as short as 1 min reduced the initial virus concentration by more than 4-log. This study demonstrates the effective strong virucidal effect of the lozenge, with the possibility of viral load reduction in the oral cavity and, consequently, reduced risk of viral transmission. View Full-Text
Keywords: cetylpyridinium chloride; benzydamine hydrochloride; SARS-CoV-2; respiratory tract infections cetylpyridinium chloride; benzydamine hydrochloride; SARS-CoV-2; respiratory tract infections
Show Figures

Figure 1

MDPI and ACS Style

Steyer, A.; Marušić, M.; Kolenc, M.; Triglav, T. A Throat Lozenge with Fixed Combination of Cetylpyridinium Chloride and Benzydamine Hydrochloride Has Direct Virucidal Effect on SARS-CoV-2. COVID 2021, 1, 435-446. https://doi.org/10.3390/covid1020037

AMA Style

Steyer A, Marušić M, Kolenc M, Triglav T. A Throat Lozenge with Fixed Combination of Cetylpyridinium Chloride and Benzydamine Hydrochloride Has Direct Virucidal Effect on SARS-CoV-2. COVID. 2021; 1(2):435-446. https://doi.org/10.3390/covid1020037

Chicago/Turabian Style

Steyer, Andrej, Miša Marušić, Marko Kolenc, and Tina Triglav. 2021. "A Throat Lozenge with Fixed Combination of Cetylpyridinium Chloride and Benzydamine Hydrochloride Has Direct Virucidal Effect on SARS-CoV-2" COVID 1, no. 2: 435-446. https://doi.org/10.3390/covid1020037

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop